DHCQT73Diversified Healthcare Trust·NASDAQ
7.74-0.51%
Filing
Down 0.5% — Filed an 8-K material-event report (2026-11-02) — details in the filing.
Medium confidence
TA
Loading chart...
Signal & projected range
Earnings big miss — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
Index—P/E—EPS (ttm)-1.11Insider Own27.55%Shs Outstand242.13MPerf Week-0.64%
Market Cap1.87BForward P/E—EPS next Y-0.40Insider Trans—Shs Float201.60MPerf Month0.13%
Enterprise Value4.18BPEG—EPS next Q—Short Float5.83%Perf Quarter-12.05%
Income-265.00MP/S1.25EPS this Y—Short Ratio6.39Perf Half Y-0.26%
Sales1.50BP/B1.18EPS next Y—ROA-6.27%Short Interest11.75MPerf YTD59.59%
Book/sh6.54P/C16.02EPS next 5Y—ROE-16.22%52W High9.66 -19.88%Perf Year86.06%
Cash/sh0.48P/FCF—EPS past 3/5Y—ROIC-23.04%52W Low3.92 97.45%Perf 3Y277.56%
Dividend Est.0.04 (0.52%)EV/EBITDA20.67Sales past 3/5Y6.20% -1.18%Gross Margin-5.25%Volatility3.04% 2.98%Perf 5Y106.95%
Dividend TTM0.04 (0.52%)EV/Sales2.78EPS Y/Y TTM—Oper. Margin-2.08%ATR (14)0.24Perf 10Y-63.92%
Dividend Ex-DateOct 19, 2026Quick Ratio188.99Sales Y/Y TTM-1.57%Profit Margin-17.73%RSI (14)49.04Recom2.94
Dividend Gr. 3/5Y0.00% -25.98%Current Ratio188.99EPS Q/Q—SMA200.91%Beta2.23Target Price9.25
Payout—Debt/Eq1.53Sales Q/Q-4.70%SMA50-0.31%Rel Volume0.73Prev Close7.78
Employees600LT Debt/Eq1.53EarningsFeb 22SMA200-0.57%Avg Volume1.80MPrice7.74
IPO DateFeb 23, 2000Option/ShortYes / YesEPS/Sales Surpr.-40.00% —Net Debt/EBITDA11.39Volume1,311,833Change-0.51%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-18-26ReiteratedRBC CapitalSector Perform$8.00
Jun-03-26ReiteratedMaxim GroupBuy$10 → $11
May-06-26ReiteratedMaxim Group$9.50 → $10
Apr-27-26InitiatedMaximBuy$9.50
Nov-13-25UpgradeRBC CapitalUnderperform → Sector Perform
Nov-06-24ReiteratedB.Riley FinancialBuy$6.00 → $5.00
Aug-05-24ReiteratedB. Riley SecuritiesBuy$6.00
Jan-17-20DowngradeWells FargoOverweight → Equal Weight
Jan-07-20UpgradeRaymond JamesUnderperform → Perform
Apr-03-19DowngradeRBC CapitalSector Perform → Underperform
Latest News· Times ET
Nov-02-26
Oct-26-26
Oct-18-26
Oct-18-2609:00AM
Oct-11-26
Oct-11-2605:00AM
Oct-08-26
Oct-06-26
Sep-21-26
Sep-17-26
Aug-22-26
Aug-22-2606:16AM
Aug-20-26
Company

Diversified Healthcare Trust (DHC) operates as a real estate investment trust (REIT) specializing in healthcare properties. Its extensive portfolio comprises medical office buildings, life science facilities, senior living communities, and wellness centers located across the United States. DHC's management is provided by an operating subsidiary of The RMR Group Inc., an alternative asset management company headquartered in Newton, Massachusetts.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,5001,5381,4951,410—————
Cost of Goods Sold Incl. D&A1,5781,7831,2391,185—————
Gross Profit-79-245256225—————
Selling, General and Administrative Excl. Other45462726—————
Research and Development
0000—————
Other Operating Expense-92-25200—————
Operating Income-32-39230199—————
Interest Expense219204235192—————
Unusual Expense
—————————
Non-Operating Income (Expense)-14-40-364-301—————
Net Income Before Taxes-264-284-370-293—————
Income Taxes3200—————
Consolidated Net Income-265-286-370-294—————
Net Income From Continuing Operations-265-286-370-294—————
Net Income-265-286-370-294—————
EPS (Recurring)-1.11-1.19-1.55-1.23—————
EPS (Basic, Before Extraordinaries)-1.11-1.19-1.55-1.23—————
EPS (Diluted)-1.11-1.19-1.55-1.23—————
EBITDA202182230199—————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio
—————————
Price To Sales Ratio1.240.760.370.63—————
Gross Margin-5.27-15.9317.1215.96—————
Operating Margin-2.13-2.5415.3814.11—————
Net Margin-17.67-18.60-24.75-20.85—————
Shares Outstanding241240240239—————
Market Capitalization1,8651,164552894—————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$10.53$8.60$6.68$4.75$2.82● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
PORTNOY ADAM D.DirectorJun 14 '23Buy3.072,000,0006,132,60023,250,019Jun 14
PORTNOY ADAM D.DirectorJun 13 '23Buy3.031,992,2596,026,78321,250,019Jun 14
PORTNOY ADAM D.DirectorJun 12 '23Buy2.872,011,2565,778,54019,257,760Jun 14
PORTNOY ADAM D.DirectorJun 09 '23Buy2.591,905,2004,943,23217,246,504Jun 09
PORTNOY ADAM D.DirectorJun 08 '23Buy2.461,690,0004,163,82215,341,304Jun 09
PORTNOY ADAM D.DirectorJun 07 '23Buy2.342,400,0005,609,52013,651,304Jun 09
PORTNOY ADAM D.DirectorJun 06 '23Buy1.871,603,0822,991,35111,251,304Jun 06
PORTNOY ADAM D.DirectorJun 05 '23Buy1.752,318,0814,065,4509,648,222Jun 06
PORTNOY ADAM D.DirectorJun 02 '23Buy1.691,625,4812,752,7527,330,141Jun 06
PORTNOY ADAM D.DirectorJun 01 '23Buy1.471,454,3882,135,9145,704,660Jun 01
PORTNOY ADAM D.DirectorMay 31 '23Buy1.351,065,0001,436,1534,250,272Jun 01
PORTNOY ADAM D.DirectorMay 30 '23Buy1.21635,253771,2613,185,272Jun 01
HARRINGTON JOHN L.DirectorMay 12 '21Sale3.6219,50070,5300May 12
HARRINGTON JOHN L.DirectorMay 07 '21Sale3.9026,500103,38219,500May 10
ZEYTOONJIAN FREDERICK NDirectorJul 08 '10Sale20.724,00082,8927,500Jul 09
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.